Healthcare

A class action against Allergan over recalled breast implants has lost its bid to strike out the US drug company’s defence that there was no known causal link between its implants and a certain form of cancer at the time of supply.

Norton Rose Fulbright has hired the former co-head of Baker McKenzie's Australian healthcare and life sciences group to join its corporate practice group in Sydney.

A judge has granted Johnson & Johnson's bid for soft class closure in a class action over alleged ineffective cold medications, saying it would aid in settlement negotiations. 

A judge has tossed a nuisance claim by the Perth Day Hospital against its neighbour Fitness Cartel, finding its use of the property for "hypersensitive" surgery and medical procedures was not an 'ordinary use' protected by nuisance law.

"Quite unsatisfactory", is how a judge has described a revived intellectual property dispute between German drug maker Merck KGaA and US drug company Merck Sharp & Dohme over the alleged use of the ‘Merck’ mark in Australia.

Lendlease has been tapped by Queensland as preferred contractor for the Redcliffe Hospital expansion project in Moreton Bay, a key part of the government's hospital rescue plan.

Johnson & Johnson has agreed to pay $7.9 billion to resolve multi-district litigation in the US alleging its talcum powder caused cancer, a settlement Shine Lawyers said was a positive development as it readies for a first case management hearing in its class action.

Lender RND Funding wants to revise its case against BDO Advisory and auditor Ernst & Young over advice given to defunct Adelaide company Gen1 Biotechnology, a week out from trial.

Shine Lawyers has won a 12-month extension to serve class actions three against drug companies that sell proton pump inhibitors.

The National Cancer Foundation has defeated a challenge to its Brown Nose Day trade mark used for bowel cancer fundraising, with the Full Court finding it is not deceptively similar to SIDS Kids’ Red Nose Day mark.